Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma
To access this article, please choose from the options below
PII: S0301-472X(09)00116-7
doi:10.1016/j.exphem.2009.03.008
© 2009 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
